Receptor transfer between immune cells by autoantibody-enhanced, CD32-driven trogocytosis is hijacked by HIV-1 to infect resting CD4 T cells

HIV-1 劫持了自身抗体增强的、CD32 驱动的吞噬作用介导的免疫细胞间受体转移,从而感染静息 CD4 T 细胞。

阅读:2
作者:Manuel Albanese,Hong-Ru Chen,Madeleine Gapp,Maximilian Muenchhoff,Hsiu-Hui Yang,David Peterhoff,Katja Hoffmann,Qianhao Xiao,Adrian Ruhle,Ina Ambiel,Stephanie Schneider,Ernesto Mejías-Pérez,Marcel Stern,Paul R Wratil,Katharina Hofmann,Laura Amann,Linda Jocham,Thimo Fuchs,Alessandro F Ulivi,Simon Besson-Girard,Simon Weidlich,Jochen Schneider,Christoph D Spinner,Kathrin Sutter,Ulf Dittmer,Andreas Humpe,Philipp Baumeister,Andreas Wieser,Simon Rothenfusser,Johannes Bogner,Julia Roider,Percy Knolle,Hartmut Hengel,Ralf Wagner,Vibor Laketa,Oliver T Fackler,Oliver T Keppler

Abstract

Immune cell phenotyping frequently detects lineage-unrelated receptors. Here, we report that surface receptors can be transferred from primary macrophages to CD4 T cells and identify the Fcγ receptor CD32 as driver and cargo of this trogocytotic transfer. Filamentous CD32+ nanoprotrusions deposit distinct plasma membrane patches onto target T cells. Transferred receptors confer cell migration and adhesion properties, and macrophage-derived membrane patches render resting CD4 T cells susceptible to infection by serving as hotspots for HIV-1 binding. Antibodies that recognize T cell epitopes enhance CD32-mediated trogocytosis. Such autoreactive anti-HIV-1 envelope antibodies can be found in the blood of HIV-1 patients and, consistently, the percentage of CD32+ CD4 T cells is increased in their blood. This CD32-mediated, antigen-independent cell communication mode transiently expands the receptor repertoire and functionality of immune cells. HIV-1 hijacks this mechanism by triggering the generation of trogocytosis-promoting autoantibodies to gain access to immune cells critical to its persistence.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。